Dauntless Investment Group, LLC - Significant Ownership

Signature - Title
/s/Matthew Okkerse - CFO
Location
Etna, NH
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Dauntless Investment Group, LLC.

Significant Ownership of Dauntless Investment Group, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AEON AEON Biopharma, Inc. Common 9.7% $43.3K 108K Dauntless Investment Group, LLC Feb 26, 2025
KZIA KAZIA THERAPEUTICS LTD American Depository Shares 8.4% 116K +43.6% Dauntless Investment Group, LLC Jun 30, 2025
OKYO OKYO Pharma Ltd Common 7.3% $3.91M $1.05M 2.74M +36.8% Dauntless Investment Group, LLC Jun 30, 2025
FEMY FEMASYS INC Common 5.4% $1.54M 1.43M Dauntless Investment Group, LLC Feb 18, 2025

Schedules 13D/G Reported by Dauntless Investment Group, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.